Lasse Myllylahti

Most-cited papers

1. Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT

   Lasse Myllylahti, H. Pitkänen, H. Magnani, R. Lassila

   2021Thrombosis Journal10 citations Open access

   Semantic Scholar

   Save

2. A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbidities

   Lasse Myllylahti, Leo Niskanen, Riitta Lassila, J. Haukka

   2024Diabetes & vascular disease research6 citations Open access

   Semantic Scholar

   Save

3. Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension

   Lasse Myllylahti, J. Ropponen, Mikko Lax, R. Lassila +1 more

   2023Clinical and applied thrombosis/hemostasis4 citations Open access

   Semantic Scholar

   Save

4. PB1706 Pharmacomechanical Thrombolysis for Acute Deep Vein Thrombosis: Patient Profiles and Anticoagulant Outcomes at Helsinki University Hospital

   Matti Kaksonen, Lasse Myllylahti, Johanna Kaartinen, Tímea Szántó +1 more

   2026Research and Practice in Thrombosis and Haemostasis0 citations Open access

   Semantic Scholar

   Save

5. Post-operative venous thromboembolism in advanced epithelial ovarian cancer: risk factors, tumor gene expression, and survival.

   M. Salko, Lasse Myllylahti, S. Palomino-Echeverría, J. Tapper +7 more

   2026International Journal of Gynecological Cancer0 citations Open access

   Semantic Scholar

   Save

6. National and regional incidence patterns of venous thromboembolism in Finland during 1998-2021 with corresponding mortality trends in 1998-2019

   Lasse Myllylahti, J. Haukka, Eero Hirvensalo, Riitta Lassila

   2025Thrombosis Update0 citations Open access

   Semantic Scholar

   Save